北京银行成立于1996年，是一家中外资本融合的新型股份制银行。成立以来，北京银行依托中国经济腾飞崛起的大好形势，先后实现引资、上市、跨区域等战略突破。目前，已在北京、天津、上海、西安、深圳、杭州、长沙、南京、济南、南昌、石家庄、乌鲁木齐等十余个中心城市以及香港、荷兰拥有600多家分支机构，开辟和探索了中小银行创新发展的经典模式。 截至2018年3月末，北京银行资产达到2.39万亿元，一季度实现净利润58.11亿元。成本收入比22.94%，不良贷款率1.23%，拨备覆盖率为272.68%，资本充足率12.28%，各项经营指标均达到国际银行业先进水平，公司价值排名中国区域性发展银行首位，品牌价值达448.69亿元，一级资本排名全球千家大银行63位，连续五年跻身全球银行业百强，被誉为中国最具创新能力和发展潜力的中型银行。 22年来，北京银行积极履行社会责任，在医疗、教育、慈善、赈灾等方面向社会捐助超过3.5亿元。凭借优异的经营业绩和优质的金融服务，北京银行赢得了社会各界的高度赞誉，先后荣获“全国文明单位”、“亚洲十大最佳上市银行”、“中国最佳城市商业零售银行”、“最佳区域性银行”、“最佳支持中小企业贡献奖”、“最佳便民服务银行”、“中国上市公司百强企业”、“中国社会责任优秀企业”、“最具持续投资价值上市公司”、“中国最受尊敬企业”、“最受尊敬银行”、“最值得百姓信赖的银行机构”及“中国优秀企业公民”、“最具创新银行”、“最佳互联网金融银行奖”等称号
Cancer remains a significant global health issue, exacerbated by population growth and aging. Immunotherapy has emerged as a promising treatment by leveraging the immune system to eliminate tumors. However, challenges such as inadequate immune activation, poor targeting, and side effects persist. Recent advancements in biomaterials, including liposomes, nanoparticles, micelles, and hydrogels, offer innovative solutions to these limitations. These engineered materials enhance the delivery and efficacy of immunotherapeutic agents, improve pharmacokinetics, enable controlled release, facilitate immune cell interactions, and reduce off-target toxicity. This review discusses the synergy between biomaterials and tumor immunotherapy, exploring current technologies, mechanisms, and future directions for personalized cancer treatments. Ongoing research in this interdisciplinary domain aims to develop next-generation immunotherapies with improved precision and therapeutic outcomes.
This paper examines the effect of banks’ non-interest income on various components of systemic risk and examines the moderating role of bank size. Using data from listed banks across 69 countries from 2010 to 2020, we find that an increase in non-interest income raises both the systematic and excess components of banks’ systemic risk. Contrary to the findings of De Jonghe et al. (2015), which suggest that the positive effect of non-interest income on systemic risk diminishes as bank size increases, we observe that this negative interaction effect of bank size disappears in the post-financial crisis period. Specifically, improvements in financial development significantly weaken this negative interaction effect of bank size. Additionally, the impact of different aspects of financial development on this negative interaction effect varies. We find that in countries with greater financial openness and stronger creditor protection, the negative interaction effect is significantly weakened and may even reverse. Conversely, financial innovations tend to amplify the negative interaction effect.
Although governments provide environmental subsidies to encourage firms to enhance environmental governance, whether these subsidies effectively improve disclosure quality remains uncertain. This study applies a fixed-effects model to examine the relationship between environmental subsidies and environmental disclosure quality. The results show that subsidies significantly enhance disclosure quality in the Electricity, Heat, Gas, and Water Production and Supply industry, a carbon-intensive and highly regulated sector. Larger and older firms also disclose more, whereas financial pressure undermines disclosure performance. The findings highlight the importance of linking subsidy allocation to disclosure outcomes, providing targeted support for SMEs, and strengthening regulatory oversight to improve overall disclosure quality and advance sustainable corporate development.
